essence study semaglutide EASL 2026 ESSENCE BL Ms Synopsis Slides

According to the Employee Benefit Research Institute, simulation modeling indicates that expanding GLP1 coverage can raise employer health premiums by 6% to nearly 14% annually, depending on how widely the drugs are made available and how consistently members remain on therapy

Tirzepatide activates both GLP-1 and GIP receptors, producing approximately 22% greater weight loss than semaglutide in clinical trials

Why the amount of bacteriostatic water matters Reconstitution is not just about dissolving powder

S., Bhattacharya A., Mandal S

Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose

We strive to provide a secure and reliable shopping experience from start to finish